a b s t r a c t S-nitrosylation is emerging as a key post-translational protein modification for the transduction of NO as a signaling molecule in plants. This data article supports the research article entitled "Functional and structural changes in plant mitochondrial PrxII F caused by NO" [1] . To identify the Cys residues of the recombinant PrxII F modified after the treatment with S-nitrosylating agents we performed the LC ESI-QTOF tandem MS and MALDI peptide mass fingerprinting analysis. Change in A 650 nm was monitored to estimate the thermal aggregation of citrate synthase in the presence S-nitrosylated PrxII F. The effect of the temperature on the oligomerization pattern and aggregation of PrxII F was analysed by SDS-PAGE and changes in absorbance at 650 nm, respectively.
Specifications table

Subject area Biology
More specific subject area
Biochemistry, proteomic
Type of data Graph, figure How data was acquired
Mass spectrometry (Eksigent 1D-nanoHPLC) coupled to a 5600 Triple TOF QTOF mass spectrometer (ABSciex, Framinghan, MA, USA), SDS-PAGE (BioRad), spectrophotometer (Jasco V-630) Data format Analyzed Experimental factors The recombinant pea mitochondrial PrxII F (PsPrxII F) was incubated with S-nitrosylating agents 5 mM GSNO (S-nitrosoglutathione) and the NO donor 250 μM SNP (sodium nitroprusside dehydrate) for 30 min at 30 1C.
Experimental features
The thermal aggregation of citrate synthase was evaluated by light scattering at 650 nm during 1800 s at 45 1C. S-nitrosylated PrxII F was immunoprecipited using anti-biotin antibody and then was subjected to SDS-PAGE. The visualized bands were digested and the peptides were analysed by nano LC ESI-QTOF tandem MS and MALDI peptide mass fingerprinting analysis Data source location All the analysis were performed in Spain. MS analysis was carried out in the National Biotechnology Center (CSIC, Spain).
Data accessibility
The data are provided in this article.
Value of the data
The data presented here are an advance in the knowledge of the identification of Cys residues targets of S-nitrosylation in mitochondrial PrxII F.
A novel function for S-nitrosylated PrxII F inhibiting the citrate synthase thermal aggregation is demonstrated, which could be biologically important under stress situations.
Data, experimental design, materials and methods
PsPrxII F treated with 5 mM GSNO was run in SDS-PAGE and the visualized bands were analysed by TOF QTOF mass spectrometry (Fig. 1) . S-nitrosylated PrxII F was subjected to the biotin switch method [2] and immunoprecipited using anti-biotin antibody and then was subjected to SDS-PAGE. The visualized bands were excised from the gel and digested overnight, in darkness at 37 1C, adding recombinant trypsin (Sigma-Aldrich, St-Louis, MO) at a 1:20 ratio as described in [3] . The digestion was stopped by adding 0.5% trifluoroacetic acid (TFA, Pierce Rockford, IL) and the peptides were extracted immediately, dried by speed-vacuum centrifugation and resuspended in 5 mL of initial ESI solvent solution (100% water þ0.5% formic acid). The visualized bands were digested and the peptides were analysed by nano LC ESI-QTOF tandem MS and MALDI peptide mass fingerprinting analysis. The S-nitrosylation was estimated by changes in the mass of the peptide containing the Cys residues, GVDSVIC 84 VAINDPYTVNAWAEK in the monomeric (score 98) and dimeric (73) forms of the PrxII F while KVVIFGLPGAYTGVC 59 SSK only in the monomeric form (28). Additionally, the nitrosylation of PrxII F was also verified as the incorporation of a HPDP-biotine on the Cys 59 in the dimeric form (Fig. 2) .
The thermal aggregation of CS was evaluated by light scattering at 650 nm during 1800 s at 45 1C, in the presence of GSNO (Fig. 3A) and SNP-treated (Fig. 3B ) PsPrxII F. This was assayed at molar ratio 0.5:1 and 2:1 (PsPrx IIF:CS) observing that it was also prevented at molar ratio 2:1 (PsPrx IIF:CS) while no inhibition of CS aggregation was observed at molar ratio 0.5:1 (PsPrx IIF:CS) and DTT treatedPsPrxII F. Additionally, the samples were separated into a soluble and pellet fraction and visualized on SDS-PAGE gel to identify the CS amount precipitated as consequence of its thermal aggregation. Staining of bands corroborated the results observed at 650 nm, a decrease in the intensity of the bands corresponding to pellet fraction indicated that CS thermal aggregation was prevented by GSNO and SNP-treated PsPrxII F at molar ratios 1:1, 1:2 (PsPrxII F:CS) (Fig. 3C and D) . It is noted, that the thermal aggregation of CS assayed on SDS-gel was strongly prevented at molar ratio 2:1 (PsPrxII F:CS) in presence of GSNO-treated PsPrxII F, while SNP-treated PsPrxII F prevented the thermal aggregation of CS to a slow molar ratio of 0.5:1 (PsPrxII F:CS). Experimental controls were carried out to demonstrate that PsPrxII F treated with DTT did not prevent the CS thermal aggregation and to verify that high temperature (45 1C) did not provoke the aggregation of the PsPrxII F (Fig. 4A and B) .
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None. Fig. 1 . Electrophoretic mobility on SDS-PAGE visualized by silver staining of the recombinant PsPrxII F treated with 5 mM GSNO (PrxII F GSNO) and 50 mM DTT (PrxII F-SH) (A). Peptide analysis were carried out by nano LC ESI-QTOF tandem MS analysis using an Eksigent 1D-nanoHPLC coupled to a 5600 Triple TOF QTOF mass spectrometer (ABSciex, Framinghan, MA, USA). Peptides identified as susceptible of modification (nitrosyl group) in the monomeric form in the Cys 84, GVDSVIC84VAIND-PYTVNAWAEK (B); in the monomeric form on the Cys 59 KVVIFGLPGAYTGVC59SSK (C), and dimeric form on the Cys 84 GVDSVIC84VAINDPYTVNAWAEK (D). 
